ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

GLMD Galmed Pharmaceuticals Ltd

0.3916
-0.0009 (-0.23%)
Apr 26 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Galmed Pharmaceuticals Ltd GLMD NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.0009 -0.23% 0.3916 17:30:10
Open Price Low Price High Price Close Price Previous Close
0.3949 0.367 0.3949 0.3916 0.3925
more quote information »

Recent News

Date Time Source Heading
4/04/202416:06PRNUSGalmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F..
3/15/202408:00PRNUSGalmed Announces Grant of New Patent for the Combination of..
2/14/202413:14EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/12/202415:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
11/29/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
11/22/202315:48EDGAR2Form POS AM - Post-Effective amendments for registration..
11/20/202315:37EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/20/202315:32PRNUSGalmed Announces a delay in the initiation of its Primary..
11/01/202315:15EDGAR2Form POS AM - Post-Effective amendments for registration..
9/26/202307:51EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/26/202307:30PRNUSGalmed Announces Allowance of New Patent for Aramchol for..
9/22/202315:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/22/202315:05PRNUSGalmed Pharmaceuticals Announces Receipt of Nasdaq Minimum..
9/21/202306:30EDGAR2Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..
9/20/202315:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/13/202315:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/09/202315:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/09/202315:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/02/202315:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/21/202309:12EDGAR2Form SC 13G - Statement of acquisition of beneficial..
7/18/202308:25EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/18/202308:23EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
7/14/202308:44EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/14/202308:30PRNUSGalmed Pharmaceuticals Announces Pricing of $7 Million..
7/13/202316:08EDGAR2Form F-1/A - Registration statement for certain foreign..
7/12/202316:29EDGAR2Form F-1/A - Registration statement for certain foreign..
7/10/202307:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/10/202307:00PRNUSGalmed to employ OnKai's disruptive Artificial Intelligence..
6/28/202307:40EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
6/28/202307:37EDGAR2Form F-1/A - Registration statement for certain foreign..
6/01/202307:00PRNUSGalmed Pharmaceuticals Reports First Quarter 2023 Financial..
5/09/202306:00PRNUSGalmed Announces Initiation of a Clinical Development..

Your Recent History

Delayed Upgrade Clock